about
Inflammatory status in human hepatic cirrhosisDendritic cell-based immunity and vaccination against hepatitis C virus infectionHuman immunodeficiency virus and liver disease forum 2010: conference proceedingsEx vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytesInnate immune cell networking in hepatitis C virus infectionType III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cellsMechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection.New treatments for chronic hepatitis C.Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes.Restoration of innate and adaptive immune responses by HCV viral inhibition with an induction approach using natural interferon-beta in chronic hepatitis CIncreased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infectionDifferential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection.Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.Ethanol metabolism alters major histocompatibility complex class I-restricted antigen presentation in liver cellsHCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway.Adaptive immunity to the hepatitis C virus.Dendritic cells in hepatitis C infection: can they (help) win the battle?Host genetics in immune-mediated hepatitis C virus clearance.Hepatitis C, innate immunity and alcohol: friends or foes?Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication.IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7/8 to Polarized Macrophages and Fibrocytes.Downregulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C.rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patients.The circulatory orbit of micro-RNAs in hepatitis C.Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy.
P2860
Q26778040-94B7AA46-81A4-46AB-876C-85D04F3C8ADCQ26828003-FF17A54C-BF35-4AA8-8531-071C21E37DEDQ28674930-D118031C-753A-4B5B-B360-6B0DA0E0A4A7Q33744649-952496FE-AAAD-4A22-B968-4AFEFD7FCA34Q34036392-048782EA-8C8C-415C-A002-16FC41869E3DQ34341382-1DA8AE2F-0308-4EC9-A723-2805BA45E88DQ34446790-870F828A-6A95-4C47-AC7E-45B597A205F8Q35012716-EF24D559-9B59-43B8-862B-BCD441379E27Q35042843-57B4C094-EBD3-4BF5-96FC-C7CC82FA75C0Q35771879-18842B88-F9E8-4356-910A-BA9AB1896DB5Q35833006-487CCD92-8760-489C-9D48-F8615BCF7AF3Q35896589-FC80017F-8AEA-47FC-A451-82A262ED089AQ36206644-A3796894-AB62-4A86-A5A4-D590A4B58BF2Q36335088-27B6CAC4-A489-4BD5-9D87-173FBC8A87A0Q36760150-C5CA3D30-998E-4F89-A290-9E0E68437C17Q36890411-C6324950-C298-4BD7-923A-E940566F9AE9Q37162792-50D9EF99-F824-4C6E-86C4-F22810607B5DQ37370720-1716C0E3-82A7-43F3-A5F7-360B3EF47D80Q37805839-FF8C5224-DE3F-4D48-93B9-714F1DB95B9AQ37843841-1E3905F6-12BA-4146-9567-7876F8E85632Q37862746-6649AC3D-6775-4FBC-9BBF-F13A12575905Q38349031-2E3F6E37-17EA-471B-A21D-CD6E47082EEBQ39413236-DB833AD1-8315-4E4A-BD59-E5834FC8A5BAQ39424862-6CAB853F-7C58-4244-BA12-DC7918601246Q40358165-F0E272B2-723F-4C83-87AB-A8B92F890C2CQ40706961-3A65BA12-C800-4444-A084-6F53F6C2740EQ42208077-47197DD9-96FB-4608-83F0-AA3D50AB10BCQ43434035-27A0D6EF-A81A-40D1-894D-6FB26F5C88C4Q51379841-702BCBFF-8AB7-41CC-A647-464680E6B05B
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Hepatitis C and Innate Immunity: Recent Advances
@ast
Hepatitis C and Innate Immunity: Recent Advances
@en
Hepatitis C and Innate Immunity: Recent Advances
@nl
type
label
Hepatitis C and Innate Immunity: Recent Advances
@ast
Hepatitis C and Innate Immunity: Recent Advances
@en
Hepatitis C and Innate Immunity: Recent Advances
@nl
prefLabel
Hepatitis C and Innate Immunity: Recent Advances
@ast
Hepatitis C and Innate Immunity: Recent Advances
@en
Hepatitis C and Innate Immunity: Recent Advances
@nl
P2860
P1476
Hepatitis C and Innate Immunity: Recent Advances
@en
P2093
Angela Dolganiuc
Gyongyi Szabo
P2860
P304
P356
10.1016/J.CLD.2008.03.003
P577
2008-08-01T00:00:00Z